Skip to main content

Cerebral Microbleeds and Thrombolysis for Acute Ischemic Stroke

  • Chapter
  • First Online:
Neuroprotective Therapy for Stroke and Ischemic Disease

Abstract

Cerebral microbleeds (CMB) are small MRI signal voids due to tiny hemosiderin deposits derived from red blood cell extravasation. The relationship between CMB and postthrombolysis intracerebral hemorrhage (ICH), the most feared complication of thrombolysis for acute ischemic stroke, has received considerable attention. Individual studies relating CMB and postthrombolysis ICH have generally failed to show a significant association. However, recent meta-analyses indicate that CMB presence or burden on pretreatment MRI is associated with postthrombolysis ICH. The exact nature of the CMB–postthrombolysis ICH relationship is complicated by the heterogeneous nature of CMB and their associated risk factors hypertension, cerebral amyloid angiopathy, and chronic kidney disease. CMB may be due to a primary disruption of the vessel wall (primary CMB) or may be a consequence of ischemic brain injury (secondary CMB). Clinicians making decisions regarding whether or not to offer intravenous thrombolysis to patients with acute ischemic stroke should attempt to distinguish primary from secondary CMB, as it is the former that likely create the greatest risk for postthrombolysis ICH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. del Zoppo GJ, Saver JL, Jauch EC, Adams HP (2009) Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40:2945–2948

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695–1703

    Article  CAS  PubMed  Google Scholar 

  3. Mullen MT, Pisapia JM, Tilwa S, Messe SR, Stein SC (2012) Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous intra-arterial thrombolysis. Stroke 43:2350–2355

    Article  CAS  PubMed  Google Scholar 

  4. Derex L, Nighoghossian N (2008) Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 79:1093–1099

    Article  CAS  PubMed  Google Scholar 

  5. Charidimou A, Kakar P, Fox Z, Werring DJ (2013) Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84:277–280

    Article  PubMed  Google Scholar 

  6. Shoamanesh A, Kwok CS, Lim PA, Benavente OR (2013) Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke 8(5):348–356

    Article  PubMed  Google Scholar 

  7. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S et al (2009) Cerebral microbleeds: a field guide to detection and interpretation. Lancet Neurol 8:165–174

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cordonnier C, Al-Shahi Salman R, Wardlaw J (2007) Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130:1988–2003

    Article  PubMed  Google Scholar 

  9. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR et al (2009) The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 73(21):1759–1766

    Article  CAS  PubMed  Google Scholar 

  10. Cordonnier C, Potter GM, Jackson CA et al (2009) Improving inter-rater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 40:94–99

    Article  PubMed  Google Scholar 

  11. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A et al (2008) Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 70:1208–1214

    Article  CAS  PubMed  Google Scholar 

  12. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R et al (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy related microbleeds. AJNR Am J Neuroradiol 20:637–642

    CAS  PubMed  Google Scholar 

  13. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C et al (2010) Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (Berl) 119:291–302

    Article  Google Scholar 

  14. Haacke EM, DelProposto ZS, Chaturvedi S, Sehgal V, Tenzer M, Neelavalli J et al (2007) Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 28:316–317

    CAS  PubMed  Google Scholar 

  15. Fisher M (2014) Cerebral microbleeds: where are we now? Neurology 83:1304–1305

    Article  PubMed  Google Scholar 

  16. Jeon SB, Kwon SU, Cho AH, Yun SC, Kim JS, Kang DW (2009) Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology 73:1638–1644

    Article  PubMed  Google Scholar 

  17. Tanskanen M, Mäkelä M, Myllykangas L, Rastas S, Sulkava R, Paetau A (2012) Intracerebral hemorrhage in the oldest-old: a population-based study (Vantaa 851). Front Neurol 3:103

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fisher M, French S, Ji P, Kim RC (2010) Cerebral microbleeds in the elderly: a pathological analysis. Stroke 41:2782–2785

    Article  PubMed  PubMed Central  Google Scholar 

  19. Janaway BM, Simpson JE, Hoggard N et al (2014) Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol 40:258–269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369:275–282

    Article  CAS  PubMed  Google Scholar 

  21. Trouillas P, von Kummer R (2006) Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischaemic stroke. Stroke 37:556–561

    Article  PubMed  Google Scholar 

  22. Gao Y, Churilov L, Teo S, Yan B (2015) Remote intracerebral haemorrhage post intravenous thrombolysis: experience from an Australian stroke centre. J Clin Neurosci 22(2):352–356

    Article  PubMed  Google Scholar 

  23. Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP et al (2014) Remote or extraischemic intracerebral hemorrhage–an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register. Stroke 45:1657–1663

    Article  PubMed  Google Scholar 

  24. Shoamanesh A, Yan S, Charidimou A (2015) New cerebral microbleeds and mechanism of post-thrombolysis remote intracerebral hemorrhage: “red meets white” revisited. Front Neurol 6:203

    Article  PubMed  PubMed Central  Google Scholar 

  25. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

    Article  Google Scholar 

  26. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII). Lancet 352:1245–1251

    Article  CAS  PubMed  Google Scholar 

  27. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study, a randomized controlled trial: alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 21:2019–2026

    Article  Google Scholar 

  28. Pantoni L, Fierini F, Poggesi A (2014) Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis 37(1):5–13

    Article  CAS  PubMed  Google Scholar 

  29. Werring DJ, Gregoire SM, Cipolotti L (2010) Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci 299(1–2):131–135

    Article  PubMed  Google Scholar 

  30. Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, Kastrup A et al (2006) Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37:2463–2466

    Article  PubMed  Google Scholar 

  31. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM (2007) Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 68:1020–1024

    Article  CAS  PubMed  Google Scholar 

  32. Aries MJH, Uyttenboogaart M, Vroomen PC, de Keyser J, Luijckx GJ (2010) tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 17:866–870

    Article  CAS  PubMed  Google Scholar 

  33. Shi ZS, Loh Y, Liebeskind DS, Saver JL, Gonzalez NR, Tateshima S et al (2012) Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke 43:1806–1811

    Article  PubMed  PubMed Central  Google Scholar 

  34. Charidimou A, Shoamanesh A, Wilson D, Gang Q, Fox Z, Jäger HR et al (2015) Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk updated meta-analysis. Neurology 85(11):927–934

    Article  PubMed  PubMed Central  Google Scholar 

  35. Tsivgoulis G, Zand R, Katsanos AH, Turc G, Nolte CH, Jung S et al (2016) Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis. JAMA Neurol 73(6):675–683 (published online April 18, 2016)

    Article  PubMed  Google Scholar 

  36. Dannenberg S, Scheitz JF, Rozanski M, Erdur H, Brunecker P, Werring DJ et al (2014) Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke 45:2900–2905

    Article  PubMed  Google Scholar 

  37. Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J et al (2004) Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 17:238–241

    Article  CAS  PubMed  Google Scholar 

  38. Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S et al (2005) Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 65:1175–1178

    Article  CAS  PubMed  Google Scholar 

  39. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N et al (2007) Bleeding Risk Analysis in Stroke Imaging Before Thrombolysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 38:2738–2744

    Article  PubMed  Google Scholar 

  40. Kimura K, Aoki J, Shibazaki K, Saji N, Uemura J, Sakamoto Y (2013) New Appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration. Stroke 44:2776–2781

    Article  CAS  PubMed  Google Scholar 

  41. Gratz PP, El-Koussy M, Hsieh K, von Arx S, Mono ML, Heldner MR et al (2014) Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke 45:1684–1688

    Article  PubMed  Google Scholar 

  42. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K et al (2002) Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 33:95–98

    Article  PubMed  Google Scholar 

  43. Kim HS, Lee DH, Ryu CW, Lee JH, Choi CG, Kim SJ et al (2006) Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol 186:1443–1449

    Article  PubMed  Google Scholar 

  44. Moriya Y, Takahashi W, Kijima C et al (2013) Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke. Tokai J Exp Clin Med 38:24–27

    PubMed  Google Scholar 

  45. Yan SQ, Wan JP, Guo Y, Lou M (2014) Impact of cerebral microbleeds on outcomes of acute ischemic stroke treated with intravenous thrombolysis (in Chinese). Zhejiang Da Xue Xue Bao Yi Xue Ban 43:20–27

    PubMed  Google Scholar 

  46. Yan S, Jin X, Zhang X, Zhang S, Liebeskind DS, Lou M (2015) Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis. J Neurol Neurosurg Psychiatry 86(11):1267–1272

    Google Scholar 

  47. Goyal N, Tsivgoulis G, Male S, Bhaskaran D, Alexandrov AV, Zand R (2015) Feasibility of rapid short sequence magnetic resonance imaging for screening stroke mimics within the iv-tpa treatment window: a pilot study. Poster presented at international stroke conference 2015; February 11–12, 2015; Nashville

    Google Scholar 

  48. Turc G, Sallem A, Moulin S, Tisserand M, Machet A, Edjlali M et al (2015) Microbleed status and 3-month outcome after intravenous thrombolysis in 717 patients with acute ischemic stroke. Stroke 46(9):2458–2463

    Article  CAS  PubMed  Google Scholar 

  49. Fisher M (2016) Cerebral microbleeds and thrombolysis: clinical consequences and mechanistic implications. JAMA Neurol 73(6):632–635. doi:10.1001/jamaneurol.2016.0576 (Epub ahead of print)

    Article  PubMed  Google Scholar 

Download references

Disclosures

Supported by NIH NS 20989

Dr. Fisher receives research support from Boehringer-Ingelheim and Otsuka Pharmaceutical Company, and serves on Clinical Events Committees for Covidien.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Fisher M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lee, J., Fisher, M. (2017). Cerebral Microbleeds and Thrombolysis for Acute Ischemic Stroke. In: Lapchak, P., Zhang, J. (eds) Neuroprotective Therapy for Stroke and Ischemic Disease. Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-45345-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-45345-3_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-45344-6

  • Online ISBN: 978-3-319-45345-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics